| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/25/2009 | CN100463906C Extraction method for daphnoretin |
| 02/25/2009 | CN100463678C Ifosfamide compositions for parenteral administration and a process for their preparation |
| 02/25/2009 | CN100463677C Preparation of nedaplatin freeze-dried powder injection |
| 02/24/2009 | US7495116 Phospholipid derivative |
| 02/24/2009 | US7495115 Androgens conjugated with mammalian proteins; diagnosis or treatment of solid cancer and hematological malignancies; exhibit synergistic action together with a cytoskeleton-acting drug; prostate cancer |
| 02/24/2009 | US7495114 Cytotoxic agents containing novel potent taxanes and their therapeutic use |
| 02/24/2009 | US7495110 Benzimidazole derivatives and their use as GnRH antagonists |
| 02/24/2009 | US7495104 Quinoline or quinazoline derivatives inhibiting auto-phosphorylation of fibroblast growth factor receptors |
| 02/24/2009 | US7495099 Polyethylene glycol-polyglutamic acid block copolymer conjugates with e.g. 7-ethyl-10-hydroxycamptothecin or topotecan for sustained release; water solubility, anticancer agents |
| 02/24/2009 | US7495090 An antitumor agent of polynucleotide sequence, a vector, a genetic construct, for encoding a protein |
| 02/24/2009 | US7495086 TWEAK receptor |
| 02/24/2009 | US7495081 Framework patched anti-CD20 antibody |
| 02/24/2009 | US7495021 Benzothiazole- and benzooxazole-4,7-dione, derivatives and their use as cdc25 phosphate inhibitors |
| 02/24/2009 | US7495020 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders |
| 02/24/2009 | US7495019 Benzoisoselenazole derivatives with anti-inflammation, antivirus and antithrombosis activity and their use |
| 02/24/2009 | US7495000 Variolin derivatives and their use as antitumor agents |
| 02/24/2009 | US7494997 excellent BCR-ABL tyrosine kinase inhibitory activity; to treat leukemias; 3-bromo-4-(4-methylpiperazin-1-ylmethyl)-N-{4-methyl-3-[4-(3-pyridyl)pyrimidin-2-ylamino]phenyl}benzamide; compounds with cell growth inhibitory effect |
| 02/24/2009 | US7494976 Antiinflammatory agents; anticancer agents; cholesterol binding protein |
| 02/24/2009 | US7494969 a plant-derived protein with anti-cancer properties which binds the human growth hormone-releasing hormone (hGHRH). Said protein, which is obtained from the Pilocarpus Heterophyllus plant, is particularly adapted for preparing a medicament that is intended for the treatment of cancers for which growth |
| 02/24/2009 | US7494824 Interactive system for presenting and eliminating substances |
| 02/24/2009 | US7494808 Methods and interferon deficient substrates for the propagation of viruses |
| 02/24/2009 | US7494775 Compositions, kits, and methods for identification, assessment, prevention and therapy of breast and ovarian cancer |
| 02/24/2009 | US7494666 Administering to a mammal a formualtion comprising cationic lipids/DNA complex, allowing the complex to associate with angiogenic endothelial cells of an angiogenic blood vessel for a time such that the complex enters the target cells |
| 02/24/2009 | US7494661 Methods for using tetanus toxin for beneficial purposes in animals (mammals) |
| 02/24/2009 | CA2426221C New neurokinin antagonists, processes for preparing them and pharmaceutical compositions containing these compounds |
| 02/24/2009 | CA2415364C Diagnostic and therapeutic methods based on the l1 adhesion molecule for ovarian and endometrial tumors |
| 02/24/2009 | CA2316972C Method for inhibiting cyclooxygenase-2 and tumor necrosis factor alpha |
| 02/24/2009 | CA2262582C Hcg and derivatives as matrix metalloproteases inhibitors |
| 02/24/2009 | CA2194236C Helicobacter proteins and vaccines |
| 02/24/2009 | CA2174556C Recombinant p53 adenovirus methods and compositions |
| 02/19/2009 | WO2009023845A2 Combination therapy with synthetic triterpenoids and gemcitabine |
| 02/19/2009 | WO2009023402A2 Heterocyclic compounds and uses as anticancer agents |
| 02/19/2009 | WO2009023269A2 4-(9-(3, 3-difluorocyclopentyl) -5, 7, 7-trimethyl-6-oxo-6, 7, 8, 9-tetrahydro-5h-pyrimido [4, 5-b[1, 4] diazepin-2-ylamino)-3-methoxybenzamide derivatives as inhibitors of the human protein kinases plk1 to plk4 for the treatment of proliferative diseases |
| 02/19/2009 | WO2009023265A1 Monoclonal antibody 175 targeting the egf receptor and derivatives and uses thereof |
| 02/19/2009 | WO2009022988A2 Vhz for diagnosis and treatment of cancer |
| 02/19/2009 | WO2009022897A2 Synergistic pharmaceutical composition useful for inhibiting corneal and retinal neovascularization (angiogenesis), and in other organs, in a human being or animal |
| 02/19/2009 | WO2009022721A1 Tricyclic amide compound |
| 02/19/2009 | WO2009022720A1 Five-membered heterocyclic compound |
| 02/19/2009 | WO2009022652A1 Lck-derived peptide useful for cancer vaccine therapy on cancer patient who is positive for hla-a3 supertype allele |
| 02/19/2009 | WO2009022171A1 Pyridinyiioxy pyridines as alk5 inhibitors |
| 02/19/2009 | WO2009022104A1 Fascaplysin derivatives and their use in the treatment of cancer |
| 02/19/2009 | WO2009022066A2 Novel naphthalene derivatives, process for the preparation thereof and pharmaceutical compositions containing same |
| 02/19/2009 | WO2009022065A2 Novel naphthalene derivatives, process for the preparation thereof and pharmaceutical compositions containing same |
| 02/19/2009 | WO2009022064A2 Novel naphthalene derivatives, process for the preparation thereof and pharmaceutical compositions containing same |
| 02/19/2009 | WO2009022063A2 Novel naphthalene derivatives, process for the preparation thereof and pharmaceutical compositions containing same |
| 02/19/2009 | WO2009021992A2 Fused bicyclic pyrimidines |
| 02/19/2009 | WO2009021990A1 Fused imidazoles for cancer treatment |
| 02/19/2009 | WO2009021887A1 Substituted hydantoins |
| 02/19/2009 | WO2009021869A1 Pyrazolo[3,4-d]-pyramidine derivatives as antiproliferative agents |
| 02/19/2009 | WO2009021728A2 Targeted block copolymer micelles |
| 02/19/2009 | WO2009021696A1 Azabiphenylaminobenzoic acid derivatives as dhodh inhibitors |
| 02/19/2009 | WO2009021325A1 Microrna compositions and methods for the treatment of myelogenous leukemia |
| 02/19/2009 | WO2009021322A1 Tumor cell-derived microvesicles |
| 02/19/2009 | WO2008157407A3 Thiadiazole, oxadiazole and triazole derivatives for treating leukemia |
| 02/19/2009 | WO2008156629A3 Methods and agents for inhibiting tumor growth by targeting the ssdna replication intermediate of tumor stem cells |
| 02/19/2009 | WO2008151637A3 Neuroplastin derived peptides |
| 02/19/2009 | WO2008148932A3 Glycosylasparaginase for treatment of cancers or inflammatory diseases |
| 02/19/2009 | WO2008148546A3 Composition of a first non-labeled monoclonal antibody binding to a tumor antigen and a non-cross reactive second monoclonal antibody labeled with a nir fluorescence label |
| 02/19/2009 | WO2008148057A3 Cationic lipids compositions and methods for enhancing immune responses to vaccines |
| 02/19/2009 | WO2008146165A3 Kit of parts for the treatment of cancer or infectious diseases |
| 02/19/2009 | WO2008142517A3 Synthetic peptide having anti-inflammatory and anti-microbic properties |
| 02/19/2009 | WO2008140507A9 Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereof |
| 02/19/2009 | WO2008109856A3 Methods of using diazepinone compounds in treating sodium channel-mediated diseases or conditions |
| 02/19/2009 | WO2008109352A4 Nucleic acid compounds for inhibiting akt gene expression and uses thereof |
| 02/19/2009 | WO2008100560A3 Estrogen receptor modulators, associated pharmaceutical compositions and methods of use |
| 02/19/2009 | WO2008094319A3 Methods and compositions of trail-death receptor agonists/activators |
| 02/19/2009 | WO2008046083A3 Use of oxindole compounds as therapeutic agents |
| 02/19/2009 | WO2008011992A8 Camptothecin derivatives with antitumor activity |
| 02/19/2009 | US20090049561 Non-human animal exhibiting bone metastasis of tumor cells |
| 02/19/2009 | US20090048435 Oligonucleotide modulation of cell adhesion |
| 02/19/2009 | US20090048350 Gastrointestinal absorption enhancer mediated by proton-coupled transporter and its preparing method |
| 02/19/2009 | US20090048346 Therapeutic formulations |
| 02/19/2009 | US20090048343 Compounds and Their Salts Specific to the PPAR Receptors and the EGF Receptors and Their Use in the Medical Field |
| 02/19/2009 | US20090048338 Biologically active oils |
| 02/19/2009 | US20090048332 Natural Novel Antioxidants |
| 02/19/2009 | US20090048327 Polymorphs of Pyrrole Substituted 2-Indolinone Protein Kinase Inhibitors |
| 02/19/2009 | US20090048313 enzyme synthetase, ligase and/or kinase inhibitors such as N-(3-(diethylamino)propyl)-N-(4-(2,5-dimethoxyphenyl)thiazol-2-yl)benzamide, used for treating Alzheimer's disease, strokes, diabetes, obesity, inflammation, cancer and rheumatoid arthritis |
| 02/19/2009 | US20090048308 VLA-4 Antagonists |
| 02/19/2009 | US20090048301 Heterocyclic compounds and their use as anticancer agents |
| 02/19/2009 | US20090048300 Heterocyclic Compounds |
| 02/19/2009 | US20090048292 Synergistic combination |
| 02/19/2009 | US20090048282 Pyrimidine sulfonamide analogs and their use as agonists of the wnt-beta-catenin cellular messaging system |
| 02/19/2009 | US20090048279 Quinazoline analogs as receptor tyrosine kinase inhibitors |
| 02/19/2009 | US20090048276 Inhibitors of Fatty Acid Synthase (Fas) |
| 02/19/2009 | US20090048274 PYRAZOLO[3,4-d]PYRIMIDINE DERIVATIVES |
| 02/19/2009 | US20090048271 Heterocyclic compounds and uses as anticancer agents |
| 02/19/2009 | US20090048266 Effects of Inhibitors of Fgfr3 on Gene Transcription |
| 02/19/2009 | US20090048265 Novel antitumor agents and methods of their use |
| 02/19/2009 | US20090048264 Piperazine amide derivatives |
| 02/19/2009 | US20090048259 Phthalazine compounds, compositions and methods of use |
| 02/19/2009 | US20090048254 Salts and polymorphs of a vegf-r inhibitor |
| 02/19/2009 | US20090048253 Benzenoid ansamycin derivative |
| 02/19/2009 | US20090048249 3-benzoimidazolyl-pyrazolopyridines useful in treating kinase disorders |
| 02/19/2009 | US20090048244 Pyrrolotriazine compounds as kinase inhibitors |
| 02/19/2009 | US20090048228 Heterocycle Derivatives As Histone Deacetylase (Hdac) Inhibitors |
| 02/19/2009 | US20090048226 Inhibitors of caspases |
| 02/19/2009 | US20090048222 Triaza Compound Immunoregulatory Agents |
| 02/19/2009 | US20090048219 Organic nitric oxide donor salts of nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 02/19/2009 | US20090048214 Methods for Treating Renal Tumors Using 2, 4-Pyrimidinediamine Drug and Prodrug Compounds |
| 02/19/2009 | US20090048205 Combination therapy with synthetic triterpenoids and gemcitabine |